1. Home
  2. OVID vs BOF Comparison

OVID vs BOF Comparison

Compare OVID & BOF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OVID
  • BOF
  • Stock Information
  • Founded
  • OVID 2014
  • BOF 2017
  • Country
  • OVID United States
  • BOF United States
  • Employees
  • OVID N/A
  • BOF N/A
  • Industry
  • OVID Biotechnology: Pharmaceutical Preparations
  • BOF Packaged Foods
  • Sector
  • OVID Health Care
  • BOF Consumer Staples
  • Exchange
  • OVID Nasdaq
  • BOF Nasdaq
  • Market Cap
  • OVID 20.6M
  • BOF 21.2M
  • IPO Year
  • OVID 2017
  • BOF 2023
  • Fundamental
  • Price
  • OVID $0.62
  • BOF $2.49
  • Analyst Decision
  • OVID Strong Buy
  • BOF
  • Analyst Count
  • OVID 4
  • BOF 0
  • Target Price
  • OVID $3.13
  • BOF N/A
  • AVG Volume (30 Days)
  • OVID 2.9M
  • BOF 494.2K
  • Earning Date
  • OVID 08-12-2025
  • BOF 08-13-2025
  • Dividend Yield
  • OVID N/A
  • BOF N/A
  • EPS Growth
  • OVID N/A
  • BOF N/A
  • EPS
  • OVID N/A
  • BOF N/A
  • Revenue
  • OVID $548,000.00
  • BOF $8,242,843.00
  • Revenue This Year
  • OVID N/A
  • BOF N/A
  • Revenue Next Year
  • OVID $5.32
  • BOF N/A
  • P/E Ratio
  • OVID N/A
  • BOF N/A
  • Revenue Growth
  • OVID 15.61
  • BOF 96.47
  • 52 Week Low
  • OVID $0.24
  • BOF $0.61
  • 52 Week High
  • OVID $1.47
  • BOF $4.11
  • Technical
  • Relative Strength Index (RSI)
  • OVID 68.33
  • BOF 49.02
  • Support Level
  • OVID $0.60
  • BOF $2.35
  • Resistance Level
  • OVID $0.73
  • BOF $3.10
  • Average True Range (ATR)
  • OVID 0.07
  • BOF 0.17
  • MACD
  • OVID 0.03
  • BOF -0.05
  • Stochastic Oscillator
  • OVID 69.12
  • BOF 18.67

About OVID Ovid Therapeutics Inc.

Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated pipeline of medicines with potential first-in-class drug mechanisms of action to treat seizures. This pipeline has produced two epilepsy programs with potential first-in-class mechanisms of action, and one epilepsy program with a potential best-in-class mechanism of action.

About BOF BranchOut Food Inc.

Branchout Food inc is engaged in the development, marketing, sale, and distribution of plant-based, dehydrated fruit and vegetable snacks and powders. Its products are currently manufactured for the company by contract manufacturers based in South America and North America that produce dehydrated fruit and vegetable products for the company using a new proprietary dehydration technology that it licenses from a third party. The Company's customers are located throughout the United States. Its current primary products are BranchOut Snacks, BranchOut Powders, and BranchOut Industrial Ingredients.

Share on Social Networks: